180
Participants
Start Date
February 8, 2021
Primary Completion Date
July 31, 2021
Study Completion Date
July 31, 2021
Recommended treatment schedule
Relatively selective Cox-2 inhibitors, Corticosteroids (Dexamethasone), Anticoagulants (LMW heparin), Gentle Oxygen therapy
Control treatment schedule
Treatment regimens different from the recommended one according to family phisicians personal practice.
"Clinical Reserach Center for Rare Diseases Aldo e Cele Daccò", Ranica
Mario Negri Institute for Pharmacological Research
OTHER